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Objective: Evaluate the efficacy of three regimens integrating toothpaste, toothbrush and
mouthwash in reducing dentine hypersensitivity.
Methods: Eight-week single-centre, three-cell, double-blind, randomized study was con-
ducted in the Dominican Republic. Subjects entered one of the three regimens: (1) tooth-
paste containing 8% arginine and 1450 ppm mono-fluorophosphate, in a calcium carbonate
base, a soft-bristle toothbrush followed by a mouthwash containing 0.8% arginine, PVM/MA
copolymer, pyrophosphates, and 0.05% sodium fluoride; (2) toothpaste containing 5%
potassium nitrate and 1450 ppm sodium fluoride, a soft-bristle toothbrush, followed by a
mouthwash containing 0.51% potassium chloride and 230 ppm sodium fluoride; and (3)
toothpaste containing 1450 ppm mono-fluorophosphate, a soft-bristle toothbrush followed
by a fluoride/arginine free mouthwash. Tactile and Air-Blast dentine hypersensitivity
measurements were performed at baseline, two, four, and eight weeks. For treatment group
comparisons, ANCOVA and post hoc Tukey’s pair-wise (a = 0.05) were used. Kaplan–Meier
survival analysis was performed to evaluate Time to Treatment Improvement.
Results: 120 subjects were enrolled, 118 completed the study. The Tactile hypersensitivity
mean scores showed statistically significant improvement at two, four and eight ( p  0.001)
weeks in the arginine regime; the potassium regime did not show significant ( p  0.05)
improvement. Air-Blast Hypersensitivity scores had a statistically significant decrease at
two ( p = 0.006), four ( p = 0.006) and eight ( p = 0.002) weeks in arginine and potassium
regimes ( p  0.05). The most effective treatment proved to be arginine ( p  0.05) compared
to the potassium regime.
* Corresponding author at: 1928 Calle Orquidea, Santa Marı´a, San Juan, Puerto Rico 00927, USA. Tel.: +1 787 758 3919.
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Conclusion: Arginine regimen provided the greatest reduction in Tactile and Air-Blast
dentine hypersensitivity compared to potassium and negative control regimens; and
provides faster dentine hypersensitivity relief than potassium regimen.
# 2013 Published by Elsevier Ltd.
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Dentine hypersensitivity is described as a short, sharp pain
caused when exposed dentine responds to stimuli.1 Predomi-
nantly, this sharp pain occurs when the root surface becomes
exposed through gingival recession uncovering the dentine
tubule orifices.2 It usually results as a consequence of thermal,
evaporative, tactile, osmotic, or chemical stimulus; and it
cannot be attributed to other dental conditions.3
The prevalence of dentine hypersensitivity has been
reported from 4 to 57%, in adults.4 This condition is more
common in adults from 20 to 49 years old, with highest
prevalence in ages 30–39.1 In addition, the prevalence of
dentine hypersensitivity has been described to be higher in
females than males.5 Other risk factors include: gingival
recession, removal of the tooth’s enamel, as well as,
consumption of certain foods or drinks.6–8 Chemical or
physical forces such as a change in temperature and air
movement stimulus have been associated with dental
hypersensitivity.9 Bra¨nnstro¨m’s Hydrodynamic Theory10 sug-
gests that external stimuli cause movement of the dentine
fluid in the tubules, resulting in a pressure change across
dentine.11 This stimulates intra-dental nerve response signals
that are ultimately interpreted by the brain as pain.12
The most common oral health care products for the
management of dentine hypersensitivity are toothpastes
and mouthrinses. Toothpastes containing potassium salts
are frequently used for dentine hypersensitivity.13 The
mechanism of action of these products is not clear, but it
has been proposed that the use of toothpastes leads to a
depolarization of the membrane of nerve fibres that prevent
repolarization; thus inhibiting the pain sensation.14 Potassi-
um-based toothpastes may contain additional ingredients
such as fluoride, antibacterial ingredients, crystal inhibitors
and high cleaning abrasives that can reduce hypersensitivi-
ty.14 A recent review summarizes the inconsistent evidence of
efficacy of potassium-based toothpastes in the hypersensitiv-
ity reduction compared to fluoride toothpaste.13
Clinical studies have assessed the efficacy of potassium
salt and sodium fluoride mouthrinses for the treatment of
dentinal hypersensitivity.15–17 Gillam and his coworkers
compared the effectiveness of a 3% potassium nitrate and
sodium fluoride mouthrinse with a control sodium fluoride
mouthrinse to treat cervical dentine sensitivity.18 These
authors demonstrated that the mouthrinse containing
potassium nitrate significantly reduced cervical dentine
sensitivity two and six weeks after product use compared to
the control mouthrinse. Pereira and Chava compared the
effectiveness of dentinal hypersensitivity in the treatment
of a 3% potassium nitrate and sodium fluoride mouthrinse to
a control mouthrinse containing sodium fluoride, using
tactile and cold air sensitivity.19 At six weeks, the dentinehypersensitivity of the test mouthrinse was significantly
reduced compared to the control mouthrinse that used only
the cold air technique.An arginine-calcium carbonate
desensitizing toothpaste has proven to be an effective
method for the management of dentinal hypersensitivity
in vitro and clinical studies.20 Arginine and calcium work
together to deposit a dentine-like material (calcium and
phosphate) forming a plug and a protective layer on the
surface of the dentinal tubules.21–23 Several studies have
demonstrated the effect of the arginine-calcium carbonate-
containing toothpaste on dentine hypersensitivity. A clini-
cal trial using 8.0% arginine, calcium carbonate, and
1450 ppm fluoride toothpaste reduced dentinal hypersensi-
tivity in response to Tactile and Air-Blast dentinal hyper-
sensitivity after two, four and eight weeks of product use
compared to a toothpaste containing 2% potassium ions.21 In
addition, three other studies have observed the same
results.22–24
Recently, an arginine-based mouthwash has been devel-
oped for the treatment of dentine hypersensitivity base
(Colgate-Palmolive Co., New York, NY). This mouthwash
has been evaluated in several clinical studies that demon-
strate the positive effect on reducing dentine hypersensitivi-
ty.25–28 There is no evidence that an arginine-based regimen
reduces dentine hypersensitivity. The objectives of this study
were (1) to evaluate three home care regimens, each
comprising the use of a dentifrice, toothbrush and mouthwash
on dentine hypersensitivity over an eight-week period; and (2)
to determine whether an arginine-based regimen provides
faster relief for dentine hypersensitivity than potassium-
based and sodium fluoride regimens. Our hypothesis was that
an arginine-containing regimen is more effective, thereby
providing faster relief for dentine hypersensitivity compared
to potassium and negative control regimens.
2. Materials and methods
This clinical study used a randomized; double blind, three-
treatment, parallel design. Adult subjects from a private
dental clinic in Santo Domingo, Dominican Republic area were
enrolled in the study.
Sample size was based on estimates of the standard
deviation of 0.527 for Air-Blast and 10.18 for Tactile sensitivity
scores. With a sample size of n = 120 (40 per group), this test is
capable of detecting a change of 7.2 (35%) for Air-Blast and
Tactile scores, respectively with 95% confidence, and 80%
power.
Prospective study subjects reported to the clinical facility
having refrained from all oral hygiene procedures and from
chewing gum for 8 h, and from eating and drinking for 4 h prior
to their examination.
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1. Subjects ranged between 18 and 70 years old, and in good
health.
2. Subjects possessed at least two hypersensitive teeth, which
were anterior to the molars, with demonstrated cervical
erosion, abrasion or gingival recession; and with tactile
sensitivity stimuli scores of 10–30 g of force (Yeaple Probe),
and Air-Blast stimuli scores of 2 or 3 (Schiff Cold Air
Sensitivity Scale) present and measured at the baseline
examination.
3. Subjects were available to participate during the eight-week
duration of the study, and agreed to sign an informed
consent form.
4. Subjects presenting gross oral pathology, chronic disease,
advanced periodontal disease, those who had undergone
treatment for periodontal disease (within the last 12
months), or had hypersensitive teeth with mobility greater
than one were excluded from the study.
5. Subjects with teeth that had extensive/defective restora-
tions (including prosthetic crowns), suspected pulpitis,
caries, cracked enamel or that were used as abutments for
removable partial dentures were also excluded from the
study.
6. Subjects were excluded from the study if they began taking
anticonvulsants, antihistamines, antidepressants, seda-
tives, tranquilizers, anti-inflammatory drugs or daily
analgesics within one month prior to the start of the study,
or if they start taking them during the course of the study.
7. Pregnant or lactating women, individuals who were
participating in any other clinical study or who had
participated in a desensitizing dentifrice study or had used
a desensitizing dentifrice within the last three months,
were not allowed to participate in the study.
8. Subjects with a history of allergy to the test products, or
allergies to oral care/personal care consumer products or
their ingredients, or subjects with existing medical condi-
tions, which precluded them from eating and drinking for
periods up to 4 h were also excluded from the study.
For each subject who qualified for participation in the
study, two hypersensitive teeth that satisfied the Tactile and
Air-Blast hypersensitivity enrollment criteria were identified
for evaluation throughout the study. Qualifying subjects were
sequentially randomized using a list of random numbers. The
subjects in the study were evaluated for Tactile and Air-Blast
hypersensitivity criteria at baseline, two, four and eight weeks.
To maintain the blinding of the study participants,
examiners and all study personnel, all toothpastes and
mouthwashes were over-wrapped. All test products were
distributed in sealed opaque bags in an area separate from the
examination room by site personnel not involved in the
clinical evaluations. The three product regimens were letter
coded.
The three regimens for treatment consisted: of brushing
with the assigned soft-bristle toothbrush and toothpaste for
1 min twice a day, during the morning and evening. It was
followed by rinsing with regimen’s mouthrinse:1. An arginine regimen: brushing with a toothpaste contain-
ing 8% arginine and 1450 ppm fluoride, as sodium mono-
fluorophosphate, in a calcium carbonate base; and rinsing
with 20 ml of a mouthwash (for 30 s), containing 0.8%
arginine, PVM/MA copolymer, pyrophosphates, and 0.05%
sodium fluoride, in an alcohol-free base (Colgate-Palmolive
Co., New York, NY).
2. Potassium regimen: brushing with a toothpaste containing
5% potassium nitrate and 1450 ppm fluoride, as sodium
fluoride, in a silica base; and rinsing with 15 ml of a
mouthwash (for 1 min) containing 0.51% potassium chlo-
ride and 230 ppm sodium fluoride, in an alcohol base
(GlaxoSmithKline Co., UK).
3. Negative control regimen: brushing with a toothpaste
containing 1450 ppm fluoride in a di-calcium phosphate
base; and rinsing (for 30 s) with 20 ml of a mouthwash
without fluoride or arginine (Colgate-Palmolive Co., New
York, NY).
For this study, the subjects were not allowed to employ any
additional oral hygiene procedures, such as flossing or using
inter-dental stimulators. In addition, subjects were instructed
to refrain from chewing gum for eight hours and from eating
and drinking for four hours prior to their follow-up hypersen-
sitivity evaluations. There were no other restrictions regarding
diet or smoking habits during the course of the study.
4. Clinical scoring procedures
4.1. Tactile hypersensitivity assessment
Tactile hypersensitivity was assessed using the Model 200A
Electronic Force Sensing Probe developed by Yeaple Research
of Pittsford, NY. The application of this probe for dental
hypersensitivity testing utilizing #19 explorer tip at a pre-set
force measured in grams was used.
The tactile hypersensitivity29 was evaluated as described
below:
1) The explorer tip of the probe was applied to the buccal
surface of each hypersensitive tooth at the CEJ.
The explorer tip was stroked perpendicular to the tooth
beginning at a pre-set force of 10 grams (0.01 kg) then
increased by 10 g (0.01 kg) increments until the subject
experienced discomfort, or until 50 grams of force (0.05 kg)
was applied.
Subject scores were calculated by averaging the values
measured on the two baseline-designated study teeth.
4.2. Air-Blast hypersensitivity assessment
The Air-Blast hypersensitivity was assessed as mentioned
below:
1) The sensitive tooth was isolated from the adjacent teeth
(mesial and distal) by the placement of the examiner’s
fingers over the adjacent teeth.
2) Air was delivered from a standard dental unit air syringe at
60 psi (4.22 kgf/cm2) (5 psi) (0.35 kgf/cm2), and 70 8F
Table 1 – Summary of age & gender: for subjects who completed the eight-week clinical study.
Treatment Age (years)a Gendera Total N
Mean (range) Male n (%) Female n (%)
Arginine regimen 39 (19–58) 20 (50.0%) 20 (50.0%) 40
Potassium regimen 33 (20–59) 22 (55.0%) 18 (45.0%) 40
Negative control 39 (18–61) 13 (34.2%) 25 (65.8%) 38
a No statistically significant difference was indicated between the three treatment groups with respect to either gender or age ( p > 0.05).
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surface of the hypersensitive tooth for 1 s from a distance of
approximately 1 cm.
3) The Schiff Cold Air Sensitivity Scale29 was used to assess
subject response to this stimulus. This scale was scored as
follows:
0 – Subject did not respond to air stimulus.
1 – Subject responded to air stimulus, but did not request
discontinuation of stimulus.
2 – Subject responded to air stimulus and requested
discontinuation or moved from stimulus.
3 – Subject responded to air stimulus, considered
stimulus to be painful and requested discontinuation
of the stimulus.
4.3. Oral soft and hard tissue assessment
The dental examiner visually examined the oral cavity and
peri-oral area using a dental light and dental mirror. This
examination included an evaluation of the soft and hard
palate, gingival mucosa, buccal mucosa, mucogingival fold
areas, tongue, sublingual and submandibular areas, salivary
glands, and the tonsilar and pharyngeal areas.
Oral soft and hard tissue assessments, as well as Tactile
and Air-Blast hypersensitivity follow-up evaluations of base-
line-designated study teeth, were conducted after two, four
and eight weeks of product use. The same trained and
standardized dental examiner performed all examinations,
using the same procedures as employed at baseline.
4.4. Adverse events
Adverse events were obtained from an interview with the
subjects and from a dental examination by the investigator.
5. Statistical methods
Analysis of variance (ANOVA) and an analysis of covariance
(ANCOVA) were performed to assess a reduction in hypersen-
sitivity. The baseline Tactile and Air-Blast mean scores were
compared using an (ANOVA). Then, (ANCOVA) was done to
compare the mean Tactile and Air-Blast hypersensitivity
scores of the different regimens after two, four, and eight
weeks of products use. Post hoc pair-wise mean comparisons
of the study regimens were performed using Tukey’s test. All
statistical tests of hypotheses were two-sided at significance
level of a = 0.05.
A Kaplan–Meier survival analysis was used to compare
treatment groups with respect to the time required toaccomplish time treatment improvement (TTI). A threshold
of 50% improvement in hypersensitivity score, defined as 50%
of the difference between the baseline score and the
‘‘terminal’’ score (Air-Blast = 0, tactile = 50) was used to assess
TTI.30 If a subject crossed the threshold by first post-treatment
visit, the subject’s TTI was ‘‘interval censored’’ between day 0
and 14. Similarly, subjects with threshold crossings, which
occurred after the first visit, but before the second and after
the second, but before the third visit, were interval censored
between days 14 and 28 and days 28 and 56, respectively. If a
subject did not cross the threshold by the third visit, the TTI
time for that subject was considered ‘‘right censored.’’ To
determine the statistical significant difference between argi-
nine containing regimen and potassium regimen groups a log
rank and Wilcoxon tests were performed. A level of signifi-
cance of a = 0.05 was used.
6. Results
One-hundred and twenty (120) subjects were enrolled during
the second week of October, 2011; and randomized in three
study groups of forty (40) participants. One hundred and
eighteen (118) participants completed the eight-week clinical
study during the second week of December, 2011. As depicted
in Table 1, gender ( p = 0.1601) and age ( p > 0.05) distribution in
the three regimen groups did not differ significantly statisti-
cally.
As depicted in Table 2, there were no statistically
significant differences among Tactile hypersensitivity
mean scores at baseline in the three regimens ( p > 0.05).
After two weeks of product use, subjects in the arginine-
containing regimen showed a statistically significant
improvement in baseline-adjusted mean tactile hypersen-
sitivity scores compared to potassium or negative control
regimens of 61.2%, and 92.5% ( p < 0.001), respectively. After
four weeks of product use, subjects in the arginine-
containing regimen also exhibited a statistically significant
improvement in baseline-adjusted mean Tactile hypersen-
sitivity scores compared to potassium and negative control
regimens of 54.5%, and 121% ( p < 0.001), respectively. After
eight weeks of product use, subjects in the arginine-
containing regimen demonstrated a statistically significant
improvement in baseline-adjusted mean Tactile hypersen-
sitivity scores relative to the potassium and negative
control regimens of 68.6%, and 135.7% ( p < 0.001), respec-
tively. There was no statistically significant difference
between subjects in the potassium and negative control
regimens, after two ( p = 0.430), four ( p = 0.072), and eight
( p = 0.146) weeks.
Table 3 – Summary of the Air-Blast hypersensitivity scores for subjects who completed the eight-week clinical study.
Treatment Baselinea
(mean  SD)
Two-week
(mean  SD)
% Difference two-week Four -Week
(mean  SD)
% Difference Four-Week Eight-Week
(mean  SD)
% Difference Eight-Week N
Potassium
regimen
Neg. control
regimen
Potassium
regimen
Neg. control
regimen
Potassium
regimen
Neg. control
regimen
Arginine
regimen
2.44  0.44 1.25  0.79 32.4% ( p < 0.001) 44.4% (p < 0.001) 0.90  0.72 32.8% ( p = 0.006) 58.5% ( p < 0.001) 0.61  0.82 49.6% (p = 0.002) 70.2% ( p < 0.001) 40
Potassium
regimen
2.39  0.40 1.85  0.61 – 17.8% ( p = 0.016) 1.34  0.68 – 38.2% ( p < 0.001) 1.21  0.79 – 41% ( p < 0.001) 40
Neg. control
regimen
2.43  0.42 2.25  0.55 – – 2.17  0.62 – – 2.05  0.75 – – 38
a Regimens are not statistically significantly different from each other at baseline.
Table 2 – Summary of the tactile hypersensitivity scores for subjects who completed the eight-week clinical study.
Treatment Baselinea
(mean  sd)
Two-week
(mean  sd)
% Difference two-week Four-week
(mean  SD)
% Difference four-week Eight-week
(mean  SD)
% Difference eight-week n
Potassium
regimen
Neg. control
regimen
Potassium
regimen
Neg. control
regimen
Potassium
regimen
Neg. control
regimen
Arginine
regimen
10.13  0.79 19.75  10.37 61.2%
( p < 0.001)
92.5%
( p < 0.001)
25.88  12.5 54.5%
( p < 0.001)
121%
( p < 0.001)
32.88  14.23 68.6%
( p < 0.001)
135.7%
( p < 0.001)
40
Potassium
regimen
10.25  1.10 12.25  4.52 – 19.4%
(p = 0.430)
16.75  8.96 – 0.43%
( p = 0.072)
19.50  11.42 – 39.8%
( p = 0.146)
40
Neg. control
regimen
10.00  0.00 10.26  1.13 – – 11.71  4.10 – – 13.95  7.46 – – 38
a Regimens are not statistically significantly different from each other at baseline ( p > 0.05).
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Table 4 – Analysis of Time to Improvementfor Subjects Who Completed the Eight-Week Clinical Study.
Measurement Threshold p-Value for differences
in TTI distributions be-
tween products
Mean (days) Median (days)
Log rank Wilcoxon Arginine
regimen
Potassium
regimen
Arginine
regimen
Potassium
regimen
Tactile 50%
Improvement
p = 0.001 p = 0.002 43.4 50.1 56 n/ay
Air-Blast 50%
Improvement
p = 0.001 p  0.001 24.5 37.8 14 28
y n/a indicates that the median could not be calculated due to the treatment group not crossing the 50th percentile threshold.
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significant differences among Air-Blast hypersensitivity
mean scores at baseline in the three regimens of treatments
( p > 0.05). After two weeks of product use, subjects in the
arginine-containing regimen showed a statistically signifi-
cant reduction in baseline-adjusted mean Air-Blast hyper-
sensitivity scores compared to the potassium and the
negative control regimens of 32.4%, and 44.4% ( p < 0.001),
respectively. Furthermore, the subjects in the potassium
regimen showed a statistically significant reduction in
baseline-adjusted mean scores compared to the negative
control regimen of 17.8% ( p = 0.016), after two weeks. After
four weeks of product use, subjects in the arginine-
containing regimen showed a statistically significant
reduction in baseline-adjusted mean Air-Blast hypersensi-
tivity scores relative to the potassium or negative control
regimens of 32.8% ( p = 0.006), and 58.5% ( p < 0.001), respec-
tively. Subjects in the potassium regimen also exhibited a
statistically significant reduction in baseline-adjusted
means relative to the negative control regimen of 38.2%
( p < 0.001), after four weeks. After eight weeks of product
use, subjects in the arginine-containing regimen presented
statistically significant reduction in baseline-adjusted
mean Air-Blast hypersensitivity scores relative to the
potassium regimen and negative control regimen of
49.6% ( p = 0.002) and 70.2% ( p < 0.001), respectively. In
addition, subjects in the potassium regimen exhibited a
statistically significant reduction in baseline-adjusted
means relative to the negative control regimen of 41%
( p < 0.001), after eight weeks.
Table 4 presents the results of the Tactile and Air-Blast
Kaplan–Meier Time Treatment Improvement Analysis (TTI). A
comparison of the mean TTI times for the two regimens
showed that the arginine-containing regimen group had lower
mean TTI for both tactile (24.5 vs. 37.8 days) and Air-Blast (43.4
vs. 50.1 days) sensitivity. The log rank and Wilcoxon test
analysis showed that the arginine-containing regimen group
had faster sensitivity relief compared to subjects in the
potassium regimen group for both Tactile ( p = 0.001 and
p = 0.002), respectively) and Air-Blast ( p = 0.001 and p < 0.001,
respectively) sensitivity.
7. Discussion
The objectives of this study were to evaluate the efficacy of
three dental regimens of toothpaste, toothbrush, andmouthwash in reducing dentine hypersensitivity after an
eight-week period; and to determine whether the arginine-
containing regimen provides faster relief than the regimen
based on Potassium in dentine hypersensitivity. We hypothe-
sized that the arginine-containing regimen is more effective,
and provides dentine hypersensitivity relief significantly
faster than the potassium and negative control regimens.
Indeed, in this study the arginine-containing regimen was
shown to be more effective than a regimen consisting of
potassium-based toothpaste and mouthwash and to negative
control regime. Nevertheless, the potassium-based regimen
provided inconsistent results in our study. The potassium-
based regime provided dentine hypersensitivity relief com-
pared to the negative control regimen when measured using
the Air-Blast technique, but it did not provide dentine
hypersensitivity relief when measured using tactile scores.
Finally, the TTI analysis demonstrated that the dentine
hypersensitivity relief provided by the arginine containing
regimen was faster than the potassium regimen.
To the best of our knowledge this is the first clinical trial
that reports the efficacy of an arginine-containing regimen for
the relief of dentine hypersensitivity. However, previous
clinical trials have established the efficacy of arginine-
containing toothpastes against potassium-based and sodium
fluoride toothpastes in the treatment of dentine hypersensi-
tivity.21–24,31 Moreover, two additional studies have shown
reduction in dentine hypersensitivity using arginine com-
pared to potassium-based and negative control
mouthwashes.16,17 Inconsistent results have been reported
when comparing to potassium-based and sodium fluoride
toothpastes in the relief in dentine hypersensitive.15–19,32
Similar results were found in our study.
8. Conclusion
This study demonstrated that an arginine-containing regimen
significantly reduced Tactile and Air-Blast dentine hypersen-
sitivity compared to potassium and negative control regimens.
Also, the arginine-containing regimen provided significantly
faster dentine hypersensitivity relief compared to the potas-
sium-containing regimen.
The present study was approved and registered in ‘‘Con-
cordia Clinical Research, Institutional Review Board’’ under
IRB #175E.
This study was sponsored by Colgate-Palmolive, New York,
NY.
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